Page 40

junjul14

Innovations in Biomedical Materials: Focus on Ceramics Program Wednesday, July 30, 2014 4 to 5:30 p.m. Opening Session – Rapid-Fire Presentations 5:30 to 7 p.m. Welcome Reception & Poster Session Thursday, July 31, 2014 8:30 to 9:30 a.m. Plenary Session I Affordable Healthcare? Role of Bioceramic Technology, Socioeconomic, and Ethical Issues Larry Hench, university professor of engineering, Florida Institute of Technology, and inventor of Bioglass® 10 to 11 a.m. Orthopedics I Panel Discussion This session discusses new and emerging bioceramic technologies and technologies that are in the commercial pipeline. It will focus on bioceramics with orthopedic applications, including cranial, facial, orthopedic, bone void fillers, and spinal applications. Individual panelists will discuss the many uses of bioactive glass for the treatment of bone injuries and bone defects in the body. It will explore material properties and forms along with dynamic bioactive bone graft material that can be molded into desired shapes for implantation. Confirmed Panelists: · Zehra Tosun, senior R&D biomedical engineer, NovaBone Products LLC · Charanpreet S. Bagga, president and CEO, Prosidyan Inc. · Markus Reiterer, senior principal scientist, Corp. Core Technologies, Medtronic Inc. · Larry Hench, university professor of engineering, Florida Institute of Technology 11 a.m. to 12 p.m. New Technologies Panel Discussion This panel discussion focuses on emerging bioceramic technologies for wound care, bone grafting, drug delivery, and coatings, including research to increase the lifetime of biomedical implants and dental materials. Specific topics include emerging topics of bioactive glasses, including new frontiers in wound care and bone grafting. In addition, drug delivery will be discussed, including nanoparticulate alternatives for drug delivery, porous silica microspheres for medical applications, and coating technologies for medical implants. Confirmed Panelists: · James H. Adair, CSO, Keystone Nanos and professor, Pennsylvania State University · George Wicks, president, Wicks Consulting Services · Orville Bailey, president, Covalent Coatings Technologies LLC · Jacob J. Stiglich, Ultramet Inc. 1:30 to 2:30 p.m. Plenary Session II The Current Regulatory Environment Glenn Stiegman, vice president, regulatory affairs, Musculoskeletal Clinical Regulatory Advisers LLC (MCRA) 3 to 4 p.m. Regulatory Panel Discussion This panel discussion focuses on the current regulatory environment, Food and Drug Administration trends, obtaining and maintaining compliance, patent trends, and protecting intellectual property. Confirmed Panelists: · Aditya Sukthankar, regulatory consultant, MDI Consultants Inc. · Tram Nguyen, partner, Monument IP Law Group · Glenn Stiegman, vice president, regulatory affairs, Musculoskeletal Clinical Regulatory Advisers LLC (MCRA) 4 to 5 p.m. Radiotherapeutics Panel Discussion The panel will discuss clinical efficacy of tenured products along with new treatment options from emerging technologies and applications. Panelists will discuss product development, materials requirements, properties of good radiotherapeutic materials, chemical durability, maximizing specific activity, method of activation, and the right type of radioisotope. Confirmed Panelists: · Mark Tann, associate professor of clinical radiology, Indiana University School of Medicine · Wayne Mullet, director of development, BTG International Canada Inc. · Delbert Day, Curators’ Professor Emeritus of materials science & engineering, Missouri University of Science and Technology Friday, August 1, 2014 8:30 to 9:30 a.m. Plenary Session III Clinical Testing Safdar Khan, M.D., chief, Division of Spine, The Ohio State University 10 to 11 a.m. Clinical Testing Panel Discussion This panel discussion focuses on the efficacy of a multitude of products from a variety of medical fields and how these products may be improved to get an improved outcome. Panelists will cover preliminary and primary research, testing required for commercialization, and clinical trials. Confirmed Panelists: · Paul M. Weinberger, assistant professor, Georgia Regents University · Ben Tempel, CEO, NanOphthalmics · Safdar Khan, M.D., chief, Division of Spine, The Ohio State University 38 www.ceramics.org | American Ceramic Society Bulletin, Vol. 93, No. 5


junjul14
To see the actual publication please follow the link above